Sb Investment Advisers (Uk) LTD Guardant Health, Inc. Transaction History

Sb Investment Advisers (Uk) LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$28.82 - $77.35 $14.5 Million - $39 Million	-503,592 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$88.71 - $120.43 $8.9 Million - $12.1 Million	-100,351 Reduced 16.62%	503,592 $50.4 Million
Q2 2021 Aug 16, 2021	SELL	$109.77 - $165.68 $612 Million - $924 Million	-5,576,587 Reduced 90.23%	603,943 $75 Million
Q1 2021 May 17, 2021	SELL	$127.04 - $179.1 $20 Million - $28.2 Million	-157,430 Reduced 2.48%	6,180,530 $943 Million
Q4 2020 Feb 16, 2021	SELL	$99.96 - $135.93 $770 Million - $1.05 Billion	-7,700,000 Reduced 54.85%	6,337,960 $817 Million
Q2 2020 Aug 17, 2020	SELL	$60.49 - $97.5 $539 Million - $869 Million	-8,912,500 Reduced 38.83%	14,037,960 $1.14 Billion
Q3 2019 Nov 14, 2019	SELL	$62.59 - $110.3 $307 Million - $540 Million	-4,900,000 Reduced 17.59%	22,950,460 $1.46 Billion
Q1 2019 May 15, 2019	BUY	$34.3 - $97.98 $69.8 Million - $199 Million	2,033,990 Added 7.88%	27,850,460 $2.14 Billion
Q4 2018 Feb 13, 2019	BUY	$29.2 - $46.1 $754 Million - $1.19 Billion	25,816,470 New	25,816,470 $970 Million

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.23B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Sb Investment Advisers (Uk) LTD, based on Form 13F filings with the SEC.

Stay updated on Sb Investment Advisers (Uk) LTD with notifications on news.